| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Executive Chairman | Director
2 companies
Dukes Iain D. is a Chief Executive Officer at TRAW with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $483K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 32,000 | $9.15 | $292,800.00 | +145.5% | -14.0% | -53.0% | |
| Nov 23, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 10,000 | $6.10 | $61,000.00 | +83.3% | +13.0% | -6.9% | |
| Dec 18, 2018 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 12,000 | $8.65 | $103,796.40 | New | - | - |